Innovative Eyewear (LUCY) Cash from Financing Activities (2021 - 2025)
Innovative Eyewear's (LUCY) quarterly Cash from Financing Activities came in at $336965.0 in Q4 2025, up 275.03% year-on-year from $89851.0 in Q4 2024, and down 42.34% quarter-over-quarter from $584402.0 in Q3 2025.
Innovative Eyewear (LUCY) Cash from Financing Activities (2021 - 2025) Analysis & Trends
Innovative Eyewear has disclosed Cash from Financing Activities across 5 years of filings, most recently posting $336965.0 for Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at $336965.0, up 275.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.0 million (down 40.99% YoY), and the FY2025 annual result was $6.7 million, down 34.77% from the prior year.
- Cash from Financing Activities came in at $336965.0 for Q4 2025 at Innovative Eyewear, down from $584402.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $6.0 million in Q3 2022 to a low of -$285137.0 in Q4 2023.
- The 5-year median for Cash from Financing Activities is $481528.0 (2021), against an average of $1.6 million.
- Across the five-year window, Cash from Financing Activities plunged 145.15% in 2022 and soared 24865.23% in 2024, its largest moves.
- Innovative Eyewear's Cash from Financing Activities stood at $449593.0 in 2021, then slumped by 145.15% to -$203000.0 in 2022, then tumbled by 40.46% to -$285137.0 in 2023, then jumped by 131.51% to $89851.0 in 2024, then jumped by 275.03% to $336965.0 in 2025.
- The last three Cash from Financing Activities figures came in at $336965.0 (Q4 2025), $584402.0 (Q3 2025), and $89851.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Innovative Eyewear | 3.44 Mn | -4.35 Mn | 114,746.00 | 336,965.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336,965.00 |
| Dec 31, 2025 | 336,965.00 |
| Sep 30, 2025 | 584,402.00 |
| Sep 30, 2025 | 584,402.00 |
| Dec 31, 2024 | 89,851.00 |
| Dec 31, 2024 | 89,851.00 |
| Sep 30, 2024 | 5.03 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Mar 31, 2024 | -75,988.00 |
| Mar 31, 2024 | -75,988.00 |
| Dec 31, 2023 | -285,137.00 |
| Dec 31, 2023 | -285,137.00 |
| Sep 30, 2023 | -20,325.00 |
| Sep 30, 2023 | -20,325.00 |
| Jun 30, 2023 | 5.61 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.36 Mn |